North America Ophthalmic Drugs Market – Size, Outlook, Trends, and Forecast (2024 – 2032)

Published : 30 Aug 2024

Report Type : Regional

Share This On

Download Free Sample Now Buy This Report

Home > Reports > Pharmaceuticals > Healthcare > North America Ophthalmic Drugs Market – Size, Outlook, Trends, and Forecast (2024 – 2032)

Description Table of Contents Scope of the Report

North America Ophthalmic Drugs Market - Size

Study Period

2018 - 2030

Base Year For Estimation

2023

Forecast Data Period

2024-2030

Historical Data Period

2018-2021

CAGR

7 %

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Ophthalmic drugs are the type of drugs which are used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders. According to the American Academy of Ophthalmology, 11.3 million people in the U.S. suffer from age-related macular degeneration (AMD), while approximately 10% of them are inflicted with wet AMD. Such trends in ophthalmic disorders across the globe contribute to the growth of the market.

North America Ophthalmic Drugs Market Segments Size & Growth:

North America Ophthalmic Drugs market size is projected to reach approximately $15.22 billion by the end of 2024 with a CAGR of close to 4.8% from $15.5 billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include Availability of new drugs and devices, the Huge demographic shift towards the emerging markets and Increase in the cataract population and so on. However, Increasing healthcare costs and an Economic slowdown in developed markets are thereby hampering

North America Ophthalmic Drugs Market - Growth

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

the market growth.

North America Ophthalmic Drugs Market Segments Share:

North America Ophthalmic Drugs Market is categorised into drugs which comprise of Ophthalmic swelling, Mydriasis drugs, Ophthalmic inflammation drugs, Anti-glaucoma drugs and so on. Among the Drugs, Ophthalmic Infection Drugs market segment dominated the Ophthalmic Drugs market in 2018. By Geography, North America is expected to dominate the Ophthalmic Drugs market and the growth in the North America economies is mainly attributed because of higher uptake of advanced novel products and techniques, and the high cost of therapies among all regions. The market in North America is expected to become worth US$13.78 billion by 2024.

North America Ophthalmic Drugs Market Trends:

Roche’s ophthalmic research programs are mainly focused on addressing the leading causes of blindness, including neovascular age-related macular degeneration (AMD), diabetic macular oedema, glaucoma, geographic atrophy secondary to AMD and other retinal diseases.
EyeGate Pharmaceuticals, Inc., a clinical-stage, speciality pharmaceutical company with two platform technologies for treating diseases and disorders of the eye, today announced that it had been granted U.S. Patent No. 9,820,935, by the U.S. Patent

You can also purchase parts of this report. Do you want to check out a section wise price list

North America Ophthalmic Drugs Market - Porter's Five Force Analysis

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

and Trademark Office (USPTO). The patent, titled “Delivery of corticosteroids through iontophoresis,” covers the iontophoretic delivery of a dexamethasone phosphate formulation to a subject’s eye for the treatment of various conditions, including post-operative inflammation and uveitis.

North America Ophthalmic Drugs Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The primary market players, such as

Carl-Zeiss AG,
Ellex Medical Lasers Ltd.
Hoya Corporation
Novagali Pharma S A
Abbott Medical Optics,

Exclusive Benefits

Credibility and
Transparency

We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.

Exhaustive
Coverage

Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.

Competitive
Edge

Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.

Golden
pportunities

Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.

Top-notch Reportsd
Guaranteed

Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.

Post Purchase
Support

Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.